<DOC>
	<DOCNO>NCT00251238</DOCNO>
	<brief_summary>The aim study investigate efficacy safety EGb 761® patient primary Raynaud phenomenon , regard frequency , duration severity vasospastic attack .</brief_summary>
	<brief_title>Efficacy Tolerability Ginkgo Biloba Extract Patients With Raynaud´s Phenomenon</brief_title>
	<detailed_description>Despite 150 year research pathophysiology Raynaud´s phenomenon still understand sufficiently . Three mean mechanism responsible Raynaud´s phenomenon discuss fall follow three category : - neurological malfunction - pathological blood vessel wall blood cell interaction - inflammatory immunological response Based concept different class drug test . Although therapy show effect , prolongation therapy often difficult due side-effects . Considering prevalence 5-10 % general population , still place probably need development new treatment concept . Ginkgo biloba show anti-oxidative anti-platelet activity . In small placebo control trial patient Raynaud´s phenomenon promise result Ginkgo biloba extract show . EGb 761® know safe well tolerate . Based consideration , EGb 761® may effective treatment Raynaud´s phenomenon . Aim : To determine efficacy safety EGb 761® patient Raynaud´s phenomenon frequency , duration , severity vasospastic attack compare placebo .</detailed_description>
	<mesh_term>Raynaud Disease</mesh_term>
	<criteria>Primary Raynaud´s phenomenon History episodic digital toe pallor Duration Raynaud´s phenomenon least 2 year Suffering form regular occuring attack prior enrolment Secondary Raynaud´s phenomenon Connective tissue disease Large vessel disease Cryoglobulinemia , cold agglutinin disease , thrombocytosis Concomitant pharmacological treatment effect vasculature Pregnancy lactation Severe internal systemic disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>Raynaud´s phenomenon</keyword>
	<keyword>Vasospastic attack</keyword>
	<keyword>Ginkgo biloba</keyword>
</DOC>